Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
isl1xenopus   

Too many results?Too few results?

Experiment details for isl1

Loss of function of Kmt2d, a gene mutated in Kabuki syndrome, affects heart development in Xenopus laevis.

Loss of function of Kmt2d, a gene mutated in Kabuki syndrome, affects heart development in Xenopus laevis.

Gene Clone Species Stages Anatomy
isl1.L laevis NF stage 14 cardiac mesoderm

  Figure 8: The development of Isl1-positive cardiac progenitor cells is largely unaffected in Kmt2d morphants. Embryos were injected with 2.5 ng MO Kmt2d (or 2.5 ng 5 bp mismatch control) or 5 ng splice MO (or 5 ng control MO) in combination with 100 pg LacZ RNA in one dorsal blastomere at the 4-cell stage. At early neurula stage 14/15 embryos were analyzed for Isl1 expression by in situ hybridizationA Uninjected control embryo; left (anterior view), right (dorsal view) of the same embryo. B Mismatch MO injected embryo. C Kmt2d MO injected embryo. D Graph summarizing three independent experiments. Standard errors of the means and numbers of analyzed embryos are shown for each condition; n.s. not significant in a Student’s t-test. E Uninjected control embryo. F Control MO injected embryo. G Splice MO injected embryo. H Graph summarizing three independent experiments. Standard errors of the means and numbers of analyzed embryos are shown for each column; n.s. not significant in a Student’s t-test.

Gene Clone Species Stages Anatomy
isl1.L laevis NF stage 29 and 30 secondary heart field

Display additional annotations [+]
  Figure 6: The expression of first and second heart field markers is affected by Kmt2d loss of function. Embryos were injected with 2.5 ng MO (Kmt2d or 5 bp mismatch control) in combination with 100 pg LacZ RNA in one dorsal blastomere at the 4-cell stage and analyzed by Tbx20 or Isl1 in situ hybridization. A Schematic drawing of Tbx20 expression in the first heart field at stage 29. B-E Embryos analyzed by Tbx20 in situ hybridization shown from the ventral side; asterisks indicate the injected side. B Uninjected control embryo. C Embryo injected with mismatch control MO. D,E Kmt2d morphant embryos showing a reduction as well as a posterior shift of Tbx20 expressing cells on the injected side. F Graph summarizing three independent injection experiments, standard errors of the means and numbers of analyzed embryos are indicated for each column. *** P-value in a Student’s t-test < 0.001. G Schematic drawing of Isl1 expression in the second heart field at stage 29. H-K Embryos analyzed by Isl1 in situ hybridization. H Uninjected control. I Mismatch control. J,K Kmt2d morphants with reduced expression of Isl1. L Graph summarizing three independent experiments, s.e.m as well as numbers of analyzed embryos are indicated. ** P-value in a Student’s t-test < 0.01.